The Role of Spleen in the Treatment of Experimental Lipopolysaccharide-induced Sepsis with Dexmedetomidine

Overview

Journal Springerplus

Date 2015 Dec 25

PMID 26702389

Citations 9

Authors

Zhaoguo Liu

Yaoqi Wang

Qiaoqing Ning

Chunzhi Gong

Yong Zhang

Li Zhang

Xiangmei Bu

Guangjian Jing

Affiliations

Soon will be listed here.

Abstract

Dexmedetomidine (Dex), a highly selective α2-adrenergic receptor agonist, has been shown to attenuate systemic inflammatory response induced by lipopolysaccharide (LPS). The protective effects of Dex may reportedly be due to the activation of the α7 nicotinic acetylcholine receptor (α7nAChR)-dependent cholinergic anti-inflammatory pathway. Spleen has been shown to play a pivotal role in the neural cholinergic anti-inflammatory pathway. However, little is known about the specific function of spleen in the protective effects of Dex against sepsis. To investigate the role of spleen in the treatment of Dex against sepsis, we studied the effects of preemptive administration of Dex to septic mice on the NF-κB p65 activation and downstream pro-inflammatory cytokine expression in the spleen. Our results provided evidence that Dex treatment attenuated LPS-activated NF-κB p65 activation, as well as the production of tumor necrosis factor-α, interleukin-6, and interleukin-1β at the level of both mRNA and protein in spleen. Consequently, serum concentrations of these cytokines decreased. Conversely, preemptive injection of α-bungarotoxin, a selective α7nAChR antagonist, reversed these effects of Dex. Our findings indicated that spleen played a critical role in the protective effects of Dex against sepsis and provided further insight into the anti-inflammatory mechanisms of Dex.

Citing Articles

Enhancing Photothermal Therapy for Antibiofilm Wound Healing: Insights from Graphene Oxide-Cranberry Nanosheet Loaded Hydrogel in vitro, in silico, and in vivo Evaluation.

Elhabal S, Al-Zuhairy S, El-Nabarawi M, Elrefai M, Shoela M, Hababeh S Int J Nanomedicine. 2024; 19:12999-13027.

PMID: 39651355 PMC: 11625196. DOI: 10.2147/IJN.S482836.

Platelet factor 4 (PF4) induces cluster of differentiation 40 (CD40) expression in human aortic endothelial cells (HAECs) through the SIRT1/NF-κB/p65 signaling pathway.

Zhong M, Wang X, Zhao Y In Vitro Cell Dev Biol Anim. 2023; 59(8):624-635.

PMID: 37728854 DOI: 10.1007/s11626-023-00808-9.

In a secondary analysis from a randomised, double-blind placebo-controlled trial Dexmedetomidine blocks cholinergic dysregulation in delirium pathogenesis in patients with major surgery.

Jacob Y, Schneider B, Spies C, Heinrich M, Von Haefen C, Kho W Sci Rep. 2023; 13(1):3971.

PMID: 36894596 PMC: 9998872. DOI: 10.1038/s41598-023-30756-z.

Dexmedetomidine suppresses serum syndecan-1 elevation and improves survival in a rat hemorrhagic shock model.

Kobayashi A, Mimuro S, Katoh T, Kobayashi K, Sato T, Kien T Exp Anim. 2022; 71(3):281-287.

PMID: 35110424 PMC: 9388338. DOI: 10.1538/expanim.21-0186.

Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury.

Karakaya D, Cakir-Aktas C, Uzun S, Soylemezoglu F, Mut M Neurocrit Care. 2021; 36(3):802-814.

PMID: 34782991 DOI: 10.1007/s12028-021-01381-3.

References

Tracey K . Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007; 117(2):289-96. PMC: 1783813. DOI: 10.1172/JCI30555. View

Ramsay M, Luterman D . Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology. 2004; 101(3):787-90. DOI: 10.1097/00000542-200409000-00028. View

Arcangeli A, DAlo C, Gaspari R . Dexmedetomidine use in general anaesthesia. Curr Drug Targets. 2009; 10(8):687-95. DOI: 10.2174/138945009788982423. View

Beutler B, Cerami A . The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol. 1989; 7:625-55. DOI: 10.1146/annurev.iy.07.040189.003205. View

Taniguchi T, Kurita A, Kobayashi K, Yamamoto K, Inaba H . Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J Anesth. 2008; 22(3):221-8. DOI: 10.1007/s00540-008-0611-9. View

Pandharipande P, Pun B, Herr D, Maze M, Girard T, Miller R . Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007; 298(22):2644-53. DOI: 10.1001/jama.298.22.2644. View

Wong G, Clark S . Multiple actions of interleukin 6 within a cytokine network. Immunol Today. 1988; 9(5):137-9. DOI: 10.1016/0167-5699(88)91200-5. View

Wang H, Yu M, Ochani M, Amella C, Tanovic M, Susarla S . Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003; 421(6921):384-8. DOI: 10.1038/nature01339. View

Hofer S, Steppan J, Wagner T, Funke B, Lichtenstern C, Martin E . Central sympatholytics prolong survival in experimental sepsis. Crit Care. 2009; 13(1):R11. PMC: 2688128. DOI: 10.1186/cc7709. View

10.

Durum S, Schmidt J, Oppenheim J . Interleukin 1: an immunological perspective. Annu Rev Immunol. 1985; 3:263-87. DOI: 10.1146/annurev.iy.03.040185.001403. View

11.

Baeuerle P, Baltimore D . I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 1988; 242(4878):540-6. DOI: 10.1126/science.3140380. View

12.

Muller J, Baeuerle P . Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology. 1993; 187(3-5):233-56. DOI: 10.1016/S0171-2985(11)80342-6. View

13.

Bohrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Mannel D . Role of NFkappaB in the mortality of sepsis. J Clin Invest. 1997; 100(5):972-85. PMC: 508272. DOI: 10.1172/JCI119648. View

14.

Parrish W, Rosas-Ballina M, Gallowitsch-Puerta M, Ochani M, Ochani K, Yang L . Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med. 2008; 14(9-10):567-74. PMC: 2435495. DOI: 10.2119/2008-00079.Parrish. View

15.

Saeed R, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, Huston J . Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med. 2005; 201(7):1113-23. PMC: 2213139. DOI: 10.1084/jem.20040463. View

16.

Huston J, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov V . Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med. 2006; 203(7):1623-8. PMC: 2118357. DOI: 10.1084/jem.20052362. View

17.

Rosas-Ballina M, Ochani M, Parrish W, Ochani K, Harris Y, Huston J . Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci U S A. 2008; 105(31):11008-13. PMC: 2504833. DOI: 10.1073/pnas.0803237105. View

18.

Carollo D, Nossaman B, Ramadhyani U . Dexmedetomidine: a review of clinical applications. Curr Opin Anaesthesiol. 2008; 21(4):457-61. DOI: 10.1097/ACO.0b013e328305e3ef. View

19.

Angus D, Lidicker J, Clermont G, Carcillo J, Pinsky M . Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29(7):1303-10. DOI: 10.1097/00003246-200107000-00002. View

20.

Borovikova L, Ivanova S, Zhang M, Yang H, Botchkina G, Watkins L . Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000; 405(6785):458-62. DOI: 10.1038/35013070. View